Robin Jones
Royal Marsden/ Institute of Cancer Research

Last Updated On 5/5/2021 4:22:21 AM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
No Relationships to Disclose

Leadership
No Relationships to Disclose

Stock and Other Ownership Interests
No Relationships to Disclose

Honoraria
No Relationships to Disclose

Consulting or Advisory Role
Company: Lilly
Recipient: You
Company: Immune Design
Recipient: You
Company: Merck Serono
Recipient: You
Company: Adaptimmune
Recipient: You
Company: Daiichi Sankyo
Recipient: You
Company: Eisai
Recipient: You
Company: Morphotek
Recipient: You
Company: TRACON Pharma
Recipient: You
Company: Immodulon Therapeutics
Recipient: You
Company: Deciphera
Recipient: You
Company: PharmaMar
Recipient: You
Company: Blueprint Medicines
Recipient: You
Company: Clinigen Group
Recipient: You
Company: Epizyme
Recipient: You
Company: Boehringer Ingelheim
Recipient: You
Company: Boehringer Ingelheim
Recipient: You
Company: Bayer
Recipient: You
Company: Karma Oncology
Recipient: You
Company: UpToDate
Recipient: You

Speakers' Bureau
No Relationships to Disclose

Research Funding
Company: GlaxoSmithKline
Recipient: Your Institution

Patents, Royalties, Other Intellectual Property
No Relationships to Disclose

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
Company: PharmaMar
Recipient: You

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
not answered

(OPTIONAL) Open Payments Link
not answered